2026 · 2nd Quarter (Apr 1 - June 30)

STERCUS BIOANALYTICS, LLC

Filed by AXADVOCACY GOVERNMENT RELATIONS.

Open official filing

Source-reported fields

Filing overview

Type: Registration
Posted: Jul 15, 2026
Income: Not reported
Expenses: Not reported
Registrant: AXADVOCACY GOVERNMENT RELATIONS
Client: STERCUS BIOANALYTICS, LLC
Filing UUID: 06c0dc74-738c-4729-9380-00b07b20133f
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

DEF · Defense

Advances to drug testing for military personnel in NDAA (Fiscal Year 2027 National Defense Authorization Act, H.R. 8800, and S. 4784.)

Literal federal measure citations: H.R. 8800, S. 4784

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.